Back to Evidence

Paper-scoped peptide mentionSequence reported

Pis v 2.0101

PMC7149036::PEP000003

Source publication

Assessment of in vitro bioactivities of Pis v 1 (2S albumin) and Pis v 2.0101 (11S globulin) proteins derived from pistachio (Pistacia vera L.)

Journal of Food Measurement and Characterization · 2020

DOI 10.1007/s11694-019-00355-6 PMC7149036

Sequence status: reported
Standardization: Sequence ready
Source location: unknown
Activity records: 34

Sequence evidence

Reported molecular identity

TNGLSQTSQLAGR

TNGLSQTSQLAGR

Resolved peptide links

PEPDIA-PLP-002822

Experimental observations

Records linked to this mention

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MIC against S. aureus (PTCC 1431) = 12 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 12 µg/mL
Target: Staphylococcus aureus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MBC against S. aureus (PTCC 1431) = 25 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 25 µg/mL
Target: Staphylococcus aureus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MIC against S. epidermis (PTCC 1435) = 12 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 12 µg/mL
Target: Staphylococcus epidermidis
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MBC against S. epidermis (PTCC 1435) = 12 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 12 µg/mL
Target: Staphylococcus epidermidis
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MIC against B. cereus (PTCC 1247) = 6.25 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 6.25 µg/mL
Target: Bacillus cereus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MBC against B. cereus (PTCC 1247) = 13.5 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 13.5 µg/mL
Target: Bacillus cereus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MIC against M. luteus (ATCC 9341) = 10 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 10 µg/mL
Target: Micrococcus luteus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram+Positive observation

Table 3: Pis v 2.0101 MBC against M. luteus (ATCC 9341) = 22 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 22 µg/mL
Target: Micrococcus luteus
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MIC against E. coli (ATCC 1533) = 50 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 50 µg/mL
Target: Escherichia coli
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MBC against E. coli (ATCC 1533) = 112 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 112 µg/mL
Target: Escherichia coli
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MIC against P. aeruginosa (PTCC 1074) = 80 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 80 µg/mL
Target: Pseudomonas aeruginosa
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MBC against P. aeruginosa (PTCC 1074) = 145 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 145 µg/mL
Target: Pseudomonas aeruginosa
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MIC against S. typhi (PTCC 1609) = 60 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 60 µg/mL
Target: Salmonella typhi
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MBC against S. typhi (PTCC 1609) = 90 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 90 µg/mL
Target: Salmonella typhi
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MIC against S. marcescens (PTCC 1267) = 60 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 60 µg/mL
Target: Serratia marcescens
Assay: Micro-dilution method

Source publication

AntimicrobialAnti-Gram-Positive observation

Table 3: Pis v 2.0101 MBC against S. marcescens (PTCC 1267) = 73.2 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MBC
Value: 73.2 µg/mL
Target: Serratia marcescens
Assay: Micro-dilution method

Source publication

AntimicrobialAntifungalPositive observation

Table 3: Pis v 2.0101 MIC against C. albicans (ATCC 10231) = 10 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 10 µg/mL
Target: Candida albicans
Assay: Micro-dilution method

Source publication

AntimicrobialAntifungalPositive observation

Table 3: Pis v 2.0101 MFC against C. albicans (ATCC 10231) = 10 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 10 (MFC)
Target: Candida albicans
Assay: Micro-dilution method

Source publication

AntimicrobialAntifungalPositive observation

Table 3: Pis v 2.0101 MIC against A. niger (ATCC 16404) = 50 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: MIC
Value: 50 µg/mL
Target: Aspergillus niger
Assay: Micro-dilution method

Source publication

AntimicrobialAntifungalPositive observation

Table 3: Pis v 2.0101 MFC against A. niger (ATCC 16404) = 50 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 50 (MFC)
Target: Aspergillus niger
Assay: Micro-dilution method

Source publication

AntiviralGeneral AntiviralPositive observation

Table 4: Pis v 2.0101 IC50 against CV-B2 = 37.50 ± 1.01 µg/mL, SI = 17.30.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 37.50 ± 1.01 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

AntiviralGeneral AntiviralPositive observation

Table 4: Pis v 2.0101 IC50 against CV-B3 = 35.61 ± 1.03 µg/mL, SI = 18.25.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 35.61 ± 1.03 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

AntiviralGeneral AntiviralPositive observation

Table 4: Pis v 2.0101 IC50 against CV-B4 = 30.20 ± 1.01 µg/mL, SI = 23.52.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 30.20 ± 1.01 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

AntiviralGeneral AntiviralPositive observation

Table 4: Pis v 2.0101 IC50 against CV-B5 = 31.77 ± 1.02 µg/mL, SI = 20.41.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 31.77 ± 1.02 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

ToxicityCytotoxicPositive observation

Table 4: Pis v 2.0101 CC50 against CV-B2 = 648.75 ± 1.02 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: CC50
Value: 648.75 ± 1.02 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

ToxicityCytotoxicPositive observation

Table 4: Pis v 2.0101 CC50 against CV-B3 = 649.88 ± 1.01 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: CC50
Value: 649.88 ± 1.01 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

ToxicityCytotoxicPositive observation

Table 4: Pis v 2.0101 CC50 against CV-B4 = 710.30 ± 1.03 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: CC50
Value: 710.30 ± 1.03 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

ToxicityCytotoxicPositive observation

Table 4: Pis v 2.0101 CC50 against CV-B5 = 648.42 ± 1.03 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: CC50
Value: 648.42 ± 1.03 µg/mL
Target: HEp-2
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against MCF-7 = 28.11 ± 0.88 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 28.11 ± 0.88 µg/mL
Target: MCF-7
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against A2780 = 33.95 ± 0.42 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 33.95 ± 0.42 µg/mL
Target: A2780
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against PC3 = 34.05 ± 0.42 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 34.05 ± 0.42 µg/mL
Target: PC3
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against DU-145 = 38.63 ± 0.80 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 38.63 ± 0.80 µg/mL
Target: DU-145
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against U-87-MG = 26.34 ± 0.88 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 26.34 ± 0.88 µg/mL
Target: U-87-MG
Assay: MTT assay

Source publication

AnticancerCytotoxicPositive observation

Table 5: Pis v 2.0101 IC50 against HTC = 28.11 ± 0.88 µg/mL.

Mention PMC7149036::PEP000003PMC7149036table

Measure: other
Value: 28.11 ± 0.88 µg/mL
Target: HTC
Assay: MTT assay

Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.